Jeffrey L. Larson - Concepedia

Concepedia

Author

Jeffrey L. Larson

Research Triangle Park Foundation

Also Known As

J L Larson, J. L. Larson, J.L. LARSON, J.L. Larson, JEFFREY L. LARSON, James L. Larson, Jeffrey L Larson, Jeffrey L. Larson, Jeffrey L. Larson

33

Publications

1.8K

Citations

21

H-Index

54

Concepts

All Affiliations

Research Triangle Park Foundation Washington State University Pfizer (United States)Centers for Disease Control and Prevention Eli Lilly (United States)

JL

About

Jeffrey L. Larson is an author at Research Triangle Park Foundation specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.1K
2	Health Sciences	6	6	433
3	Natural Sciences	2	2	104
4	Anatomy	1	1	115
5	Applied Physiology	1	1	115

Jeffrey L. Larson

×

26

Publications

1.8K

Citations

21

H-Index

	Year	Citations
Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate Richard J. Bull, Idalia M. Sanchez, Mark A. Nelson, Toxicology Tumor BiologyHepatologyOncogenic AgentMedicineLiver Physiology	1990	289
Antiretroviral Activity of the Anti‐CD4 Monoclonal Antibody TNX‐355 in Patients Infected with HIV Type 1 Daniel R. Kuritzkes, Jeffrey M. Jacobson, William G. Powderly, The Journal of Infectious Diseases	2004	193
Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice Jeffrey L. Larson, Richard J. Bull Toxicology and Applied Pharmacology Energy MetabolismBiochemistryMedicineLipid PeroxidationPhysiology	1992	156
Vital Forces: Regulative Principles or Constitutive Agents? A Strategy in German Physiology, 1786-1802 Jeffrey L. Larson Isis MechanobiologyPhysiological PrinciplePhysiological ResearchPhysiologyVital Forces	1979	115
Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein Gallen Triana‐Baltzer, Larisa V. Gubareva, John M. Nicholls, PLoS ONE	2009	107
Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma Motonari Nomura, Nino Rainusso, Yi‐Chien Lee, JNCI Journal of the National Cancer Institute	2019	98
Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate Jeffrey L. Larson, Richard J. Bull Toxicology and Applied Pharmacology Environmental ChemistryBiochemistryMedicineCarcinogenic MetabolitesToxicology	1992	94
Cloning genes for the biosynthesis of a macrolide antibiotic. Scott E. Fishman, Karen L. Cox, Jeffrey L. Larson, Proceedings of the National Academy of Sciences BiosynthesisAntimicrobial Resistance GeneStructural GeneDrug ResistanceNatural Sciences	1987	87
Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein Gallen Triana‐Baltzer, Larisa V. Gubareva, Alexander Klimov, PLoS ONE Influenza TherapiesInhibitory ActivityPathogenesisImmunologyAntiviral Therapy	2009	77
The Toxicity of Repeated Exposures to Rolipram, a Type IV Phosphodiesterase Inhibitor, in Rats Jeffrey L. Larson, Michael V. Pino, Lee E. Geiger, Pharmacology & Toxicology	1996	74

Page 1